The investigator initiated Phase I trial of ADRCs (Cytori Cell Therapy™) in the patients with post prostatectomy erectile dysfunction.

Trial Profile

The investigator initiated Phase I trial of ADRCs (Cytori Cell Therapy™) in the patients with post prostatectomy erectile dysfunction.

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 18 May 2017

At a glance

  • Drugs ECCS 50 (Primary)
  • Indications Erectile dysfunction
  • Focus Adverse reactions
  • Most Recent Events

    • 18 May 2017 New trial record
    • 10 May 2017 According to a Cytori Therapeutics Media Release, data will be presented occur at the 2017 American Urological Association Annual Meeting, and the abstract is currently available in the Journal of Urology (online).
    • 10 May 2017 According to a Cytori Therapeutics Media Release, six month follow-up data (n=17) from this trial published in EBioMedicine journal.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top